Live Demo:
This is a live DrugChatter demonstration using real AI-generated drug queries and analysis.
Want to see how your drug is represented by AI?
Contact DrugChatter
cosentyx
Brand Visibility Tracking
How this brand shows up in AI chatbot answers — presence, position, sentiment, and how it stacks up against competitors.
–
Score / 100
Latest check
Weighted composite of presence, position, sentiment, and recommendation strength across tracked prompts.
Presence
–
Avg. position
–
Lower is betterSentiment
–
Recommendation mix — latest check
How the brand was framed across the latest tracked prompts.
Competitive landscape — latest check
Visibility vs. sentiment. Bubble size reflects rank position (bigger = higher-ranked).
Best known for — latest check
Cosentyx often has that reputation.
Often produce rapid skin improvement for many patients.
Cosentyx’s marketing emphasizes it as an IL-17A inhibitor and commonly highlights outcomes in skin + joint symptoms.
Targeting IL-17A in psoriasis
Not as a strict strength ranking
Core Claims — latest check
Cosentyx often shows faster skin improvement.
Cosentyx monitoring also includes general infection/lab surveillance.
Cosentyx has been associated with IBD worsening or new IBD in some cases.
IL\u201117 blockers (like Cosentyx) are more associated with mucocutaneous fungal infections (notably yeast infections/thrush).
Cosentyx (secukinumab): blocks IL‑17A.
Differentiators — latest check
Cosentyx often shows faster skin improvement (especially early).
Cosentyx is more associated with mucocutaneous fungal infections than Humira.
Humira may be favored for Crohn's disease/ulcerative colitis history.
Cosentyx monitoring includes general infection/lab surveillance.
Cosentyx blocks IL‑17A; Stelara blocks IL‑12/23 (upstream of several inflammatory pathways).
Competitor comparison — latest check
| Brand | Visibility | Sentiment | Position | Recommended |
|---|
30-day composite trends
Score
Overall composite score, per day.
Visibility vs. sentiment
Two lenses on the same conversations — how much the brand shows up, and how it's spoken about.
Average rank position
Where the brand lands among all brands mentioned, in reading order. Lower is better.
Recent checks
| Date | Score | Visibility | Position | Sentiment |
|---|---|---|---|---|
| Jul 19, 2026 | 63 | 64 | 1 | 63 |
| Jul 20, 2026 | 58 | 61 | 1 | 62 |
| Jul 21, 2026 | 68 | 72 | 1 | 68 |
| Jul 22, 2026 | 59 | 60 | 1 | 64 |
| Jul 23, 2026 | 65 | 67 | 1 | 68 |
| Jul 24, 2026 | 58 | 60 | 1 | 61 |
| Jul 25, 2026 | 51 | 53 | 0 | 61 |
| Jul 26, 2026 | 61 | 67 | 1 | 64 |
| Jul 27, 2026 | 61 | 64 | 1 | 63 |
| Aug 1, 2026 | 61 | 66 | 1 | 66 |
| Aug 2, 2026 | 58 | 69 | 1 | 54 |
| Aug 3, 2026 | 65 | 67 | 1 | 59 |
| Aug 4, 2026 | 65 | 65 | 1 | 60 |
| Aug 5, 2026 | 62 | 64 | 1 | 56 |
| Aug 6, 2026 | 53 | 70 | 0 | 57 |
| Aug 7, 2026 | 53 | 64 | 0 | 59 |
| Aug 8, 2026 | 65 | 67 | 1 | 56 |
| Aug 9, 2026 | 58 | 62 | 1 | 58 |
| Aug 10, 2026 | 59 | 65 | 1 | 57 |
| Aug 11, 2026 | 63 | 67 | 1 | 58 |
| Aug 12, 2026 | 65 | 69 | 1 | 59 |
| Aug 14, 2026 | 64 | 68 | 1 | 60 |
| Aug 15, 2026 | 62 | 63 | 1 | 61 |